home / stock / knte / knte quote
Last: | $2.65 |
---|---|
Change Percent: | 0.38% |
Open: | $2.64 |
Close: | $2.65 |
High: | $2.675 |
Low: | $2.64 |
Volume: | 2,812,224 |
Last Trade Date Time: | 04/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.65 | $2.64 | $2.65 | $2.675 | $2.64 | 2,812,224 | 04-02-2024 |
$2.66 | $2.65 | $2.66 | $2.67 | $2.64 | 862,362 | 04-01-2024 |
$2.66 | $2.66 | $2.66 | $2.69 | $2.65 | 518,478 | 03-29-2024 |
$2.66 | $2.66 | $2.66 | $2.69 | $2.65 | 518,478 | 03-28-2024 |
$2.66 | $2.64 | $2.66 | $2.675 | $2.64 | 472,324 | 03-27-2024 |
$2.63 | $2.66 | $2.63 | $2.66 | $2.63 | 714,882 | 03-26-2024 |
$2.65 | $2.65 | $2.65 | $2.6784 | $2.64 | 340,709 | 03-25-2024 |
$2.65 | $2.65 | $2.65 | $2.6613 | $2.63 | 1,770,785 | 03-22-2024 |
$2.65 | $2.65 | $2.65 | $2.675 | $2.63 | 755,215 | 03-21-2024 |
$2.65 | $2.64 | $2.65 | $2.66 | $2.635 | 1,016,890 | 03-20-2024 |
$2.55 | $2.55 | $2.55 | $2.57 | $2.54 | 167,607 | 03-19-2024 |
$2.55 | $2.55 | $2.55 | $2.57 | $2.54 | 170,565 | 03-18-2024 |
$2.56 | $2.53 | $2.56 | $2.56 | $2.53 | 254,203 | 03-15-2024 |
$2.53 | $2.55 | $2.53 | $2.55 | $2.52 | 154,125 | 03-14-2024 |
$2.54 | $2.55 | $2.54 | $2.57 | $2.53 | 329,261 | 03-13-2024 |
$2.55 | $2.56 | $2.55 | $2.56 | $2.53 | 349,581 | 03-12-2024 |
$2.54 | $2.57 | $2.54 | $2.58 | $2.54 | 692,529 | 03-11-2024 |
$2.58 | $2.58 | $2.58 | $2.6 | $2.57 | 153,843 | 03-08-2024 |
$2.565 | $2.59 | $2.565 | $2.6012 | $2.56 | 227,052 | 03-07-2024 |
$2.57 | $2.6 | $2.57 | $2.6 | $2.57 | 74,668 | 03-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Kinnate Biopharma Inc. Company Name:
KNTE Stock Symbol:
NASDAQ Market:
Kinnate Biopharma Inc. Website:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
EMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced th...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...